James A Platts-Mills, Elias G Ayoub, Jixian Zhang, Elizabeth T Rogawski McQuade, Ahmed M Arzika, Ramatou Maliki, Amza Abdou, Jeremy D Keenan, Thomas M Lietman, Jie Liu, Eric R Houpt
{"title":"尼日尔一年两次大规模阿奇霉素治疗对5岁以下儿童肠道病原菌携带的影响","authors":"James A Platts-Mills, Elias G Ayoub, Jixian Zhang, Elizabeth T Rogawski McQuade, Ahmed M Arzika, Ramatou Maliki, Amza Abdou, Jeremy D Keenan, Thomas M Lietman, Jie Liu, Eric R Houpt","doi":"10.1093/cid/ciab1046","DOIUrl":null,"url":null,"abstract":"<p><p>We analyzed samples obtained at baseline and 24 months in a mass azithromycin administration trial in Niger using quantitative polymerase chain reaction. In villages randomized to azithromycin, Shigella was the only pathogen reduced at 24 months (prevalence ratio, 0.36 [95% confidence interval: .17-.79]; difference in log quantity, -.42 [-.75 to -.10]).</p>","PeriodicalId":10421,"journal":{"name":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America","volume":" ","pages":"515-518"},"PeriodicalIF":0.0000,"publicationDate":"2022-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427139/pdf/","citationCount":"1","resultStr":"{\"title\":\"Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger.\",\"authors\":\"James A Platts-Mills, Elias G Ayoub, Jixian Zhang, Elizabeth T Rogawski McQuade, Ahmed M Arzika, Ramatou Maliki, Amza Abdou, Jeremy D Keenan, Thomas M Lietman, Jie Liu, Eric R Houpt\",\"doi\":\"10.1093/cid/ciab1046\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We analyzed samples obtained at baseline and 24 months in a mass azithromycin administration trial in Niger using quantitative polymerase chain reaction. In villages randomized to azithromycin, Shigella was the only pathogen reduced at 24 months (prevalence ratio, 0.36 [95% confidence interval: .17-.79]; difference in log quantity, -.42 [-.75 to -.10]).</p>\",\"PeriodicalId\":10421,\"journal\":{\"name\":\"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America\",\"volume\":\" \",\"pages\":\"515-518\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-08-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427139/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/cid/ciab1046\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/cid/ciab1046","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger.
We analyzed samples obtained at baseline and 24 months in a mass azithromycin administration trial in Niger using quantitative polymerase chain reaction. In villages randomized to azithromycin, Shigella was the only pathogen reduced at 24 months (prevalence ratio, 0.36 [95% confidence interval: .17-.79]; difference in log quantity, -.42 [-.75 to -.10]).